trending Market Intelligence /marketintelligence/en/news-insights/trending/s2y2vziqcde1jtuxw_owsw2 content esgSubNav
In This List

Adverum Biotechnologies prices $60M common stock offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Adverum Biotechnologies prices $60M common stock offering

Adverum Biotechnologies Inc. priced an offering of 8,888,900 shares at $6.75 apiece to raise about $60 million in gross proceeds.

Cowen and Piper Jaffray & Co. are acting as joint book-running managers of the offering which is expected to close by Feb. 9. Raymond James is acting as lead manager.

The Menlo Park, Calif.-based company has granted the underwriters an option to purchase up to an additional 1,333,335 shares.